Pharmabiz

Glenmark Pharma receives US FDA approval for generic Inlyta tablets

Glenmark Pharma receives US FDA approval for generic Inlyta tablets: Our Bureau, Mumbai Tuesday, December 1, 2020, 13:20 Hrs [IST] Glenmark Pharmaceuticals Inc. has received tenta ...
Pharmabiz

CDR-Life announces early clinical data demonstrating pharmacodynamic activity of CDR404

CDR-Life announces early clinical data demonstrating pharmacodynamic activity of CDR404: Zurich, Switzerland Saturday, October 25, 2025, 18:00 Hrs [IST] CDR-Life, Inc, a biotechno ...
Pharmabiz

EMA grants Orphan Drug Designation to Ribo’s siRNA therapeutic RBD1016 for Hepatitis Delta Virus infection

EMA grants Orphan Drug Designation to Ribo’s siRNA therapeutic RBD1016 for Hepatitis Delta Virus infection: Beijing, China Saturday, October 25, 2025, 17:00 Hrs [IST] Suzhou Rib ...
Pharmabiz

WHO launches new country guidance for health emergency coordination

WHO launches new country guidance for health emergency coordination: Geneva Saturday, October 25, 2025, 16:00 Hrs [IST] The World Health Organization (WHO) has released a comprehe ...
Pharmabiz

Secarna Pharma inks agreement with Scenic Biotech to discover and co-develop disease-modifying oligonucleotide therapy against a novel drug target

Secarna Pharma inks agreement with Scenic Biotech to discover and co-develop disease-modifying oligonucleotide therapy against a novel drug target: Munich, Germany Saturday, Octob ...
Pharmabiz

BridgeBio Oncology announces new preclinical data of BBO-11818 demonstrating its potential as a potent panKRAS inhibitor targeting mutant KRAS

South San Francisco, California Saturday, October 25, 2025, 14:00 Hrs [IST] ...
Pharmabiz

US FDA publishes filing checklists to prevent submission delays

US FDA publishes filing checklists to prevent submission delays: Maryland Saturday, October 25, 2025, 13:00 Hrs [IST] The US Food and Drug Administration (FDA) made public filing ...
Pharmabiz

CAGE Bio begins double-blind placebo-controlled clinical trial of topical DNA Aptamer therapy CGB-600 for vitiligo treatment

CAGE Bio begins double-blind placebo-controlled clinical trial of topical DNA Aptamer therapy CGB-600 for vitiligo treatment: San Carlos, California Saturday, October 25, 2025, 12 ...
Pharmabiz

GSK’s Blenrep receives US FDA approval to treat relapsed/refractory multiple myeloma

GSK’s Blenrep receives US FDA approval to treat relapsed/refractory multiple myeloma: London, UK Saturday, October 25, 2025, 11:00 Hrs [IST] GSK plc announced the US Food and Dr ...
Pharmabiz

MERS-CoV virus isolate added to the WHO BioHub System, enabling further research and pandemic preparedness

MERS-CoV virus isolate added to the WHO BioHub System, enabling further research and pandemic preparedness: Geneva Saturday, October 25, 2025, 10:00 Hrs [IST] An isolate of Middle ...
Pharmabiz

FICCI envisages it's Smart AAMs initiative to strengthen primary healthcare

FICCI envisages it's Smart AAMs initiative to strengthen primary healthcare: Our Bureau, New Delhi Saturday, October 25, 2025, 09:30 Hrs [IST] In line with the Central Government' ...
Pharmabiz

Chugai Pharma to acquire Tokyo-based clinical biopharmaceutical company, Renalys Pharma

Chugai Pharma to acquire Tokyo-based clinical biopharmaceutical company, Renalys Pharma: Tokyo, Japan Saturday, October 25, 2025, 09:00 Hrs [IST] Renalys Pharma, Inc., a privately ...